Suppr超能文献

L1、L21和CLFP3对虹鳟鱼抗水霉病的益生菌作用有限。

Limited Probiotic Effect of L1, L21 and CLFP3 to Protect Rainbow Trout against Saprolegniosis.

作者信息

Fregeneda-Grandes Juan-Miguel, González-Palacios Concepción, Pérez-Sánchez Tania, Padilla Daniel, Real Fernando, Aller-Gancedo José-Miguel

机构信息

Departamento de Sanidad Animal, Campus de Vegazana s/n, Universidad de León, 24071 León, Spain.

Departamento Agricultura y Alimentación, Universidad de La Rioja, Avenida Madre de Dios 53, 26006 Logroño, Spain.

出版信息

Animals (Basel). 2023 Mar 6;13(5):954. doi: 10.3390/ani13050954.

Abstract

Previous studies have demonstrated that the strains L1, L21 and CLFP3 are probiotics against vibriosis or lactococosis in sea bass or rainbow trout. In this study, the utility of these bacterial strains in the control of saprolegniosis was evaluated. For this purpose, both in vitro inhibition studies and competition for binding sites against and in vivo tests with experimentally infected rainbow trout were carried out. In the in vitro tests, the three isolates showed inhibitory activity upon mycelium growth and cyst germination and reduced the adhesion of cysts to cutaneous mucus; however, this effect depended on the number of bacteria used and the incubation time. In the in vivo test, the bacteria were administered orally at 10 CFU g in the feed or at 10 CFU ml in the tank water for 14 days. None of the three bacteria showed protection against infection either through water or feed, and the cumulative mortality reached 100% within 14 days post infection. The obtained results show that the use of an effective probiotic against a certain disease in a host may not be effective against another pathogen or in another host and that the results obtained in vitro may not always predict the effects when used in vivo.

摘要

先前的研究表明,菌株L1、L21和CLFP3是针对海鲈或虹鳟鱼弧菌病或乳球菌病的益生菌。在本研究中,评估了这些细菌菌株在控制水霉病方面的效用。为此,进行了体外抑制研究、与[未提及具体对象]争夺结合位点的竞争试验以及对实验感染的虹鳟鱼进行的体内试验。在体外试验中,这三种分离株对菌丝体生长和孢囊萌发均表现出抑制活性,并减少了孢囊对皮肤黏液的黏附;然而,这种效果取决于所用细菌的数量和孵育时间。在体内试验中,以每克饲料10 CFU或每毫升养殖用水10 CFU的剂量口服给予细菌,持续14天。这三种细菌通过水或饲料给药均未显示出对[未提及具体病原体]感染的保护作用,并且在感染后14天内累计死亡率达到100%。所得结果表明,在宿主中对某种疾病有效的益生菌对另一种病原体或在另一种宿主中可能无效,并且体外获得的结果不一定总能预测其在体内使用时的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a0f/10000206/2079132fc6e5/animals-13-00954-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验